136 related articles for article (PubMed ID: 14564233)
1. The role of in-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes.
Fonarow GC
Rev Cardiovasc Med; 2003; 4 Suppl 3():S37-46. PubMed ID: 14564233
[TBL] [Abstract][Full Text] [Related]
2. The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes.
Fonarow GC
Rev Cardiovasc Med; 2002; 3 Suppl 3():S2-S10. PubMed ID: 12447156
[TBL] [Abstract][Full Text] [Related]
3. In-hospital initiation of cardiovascular protective medications for patients undergoing percutaneous coronary intervention: taking advantage of the teachable moment.
Fonarow GC
J Invasive Cardiol; 2003 Nov; 15(11):646-52. PubMed ID: 14608138
[TBL] [Abstract][Full Text] [Related]
4. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF.
Fonarow GC
Rev Cardiovasc Med; 2004; 5 Suppl 1():S45-54. PubMed ID: 15184838
[TBL] [Abstract][Full Text] [Related]
5. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
[TBL] [Abstract][Full Text] [Related]
6. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
Fonarow GC; Gheorghiade M; Abraham WT
Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
[TBL] [Abstract][Full Text] [Related]
7. Strategies to improve the use of evidence-based heart failure therapies.
Fonarow GC
Rev Cardiovasc Med; 2005; 6 Suppl 2():S32-42. PubMed ID: 15891703
[TBL] [Abstract][Full Text] [Related]
8. Role of in-hospital initiation of carvedilol to improve treatment rates and clinical outcomes.
Fonarow GC
Am J Cardiol; 2004 May; 93(9A):77B-81B. PubMed ID: 15144944
[TBL] [Abstract][Full Text] [Related]
9. How well are chronic heart failure patients being managed?
Fonarow GC
Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
[TBL] [Abstract][Full Text] [Related]
10. Improving the management of patients after myocardial infarction, from admission to discharge.
Amin A
Clin Ther; 2006 Oct; 28(10):1509-39. PubMed ID: 17157110
[TBL] [Abstract][Full Text] [Related]
11. In-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes: the University of California-Los Angeles, Cardiovascular Hospitalization Atherosclerosis Management Program.
Fonarow GC; Gawlinski A; Watson K
Crit Pathw Cardiol; 2003 Jun; 2(2):61-70. PubMed ID: 18340322
[TBL] [Abstract][Full Text] [Related]
12. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
[TBL] [Abstract][Full Text] [Related]
14. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
[TBL] [Abstract][Full Text] [Related]
15. Managed care interventions for improving outcomes in acute heart failure syndromes.
Khan SS; Gheorghiade M; Dunn JD; Pezalla E; Fonarow GC
Am J Manag Care; 2008 Dec; 14(12 Suppl Managed):S273-86; quiz S287-91. PubMed ID: 19166273
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
Borrello F; Beahan M; Klein L; Gheorghiade M
Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
[TBL] [Abstract][Full Text] [Related]
17. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
18. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
19. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
20. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
